Loading...
OTCM
RMTG
Market cap445kUSD
Jul 09, Last price  
0.04USD
1D
65.89%
1Q
42.00%
Jan 2017
-85.80%
IPO
-100.00%
Name

Meso Numismatics Inc

Chart & Performance

D1W1MN
OTCM:RMTG chart
P/E
P/S
0.09
EPS
Div Yield, %
Shrs. gr., 5y
6.22%
Rev. gr., 5y
147.35%
Revenues
5m
+24.17%
05,412029,24150,11630,10355,082475,2611,530,2232,409,9534,107,4945,100,315
Net income
-8m
L+40.44%
-3,843,362-1,926,518-4,206,292-377,007-2,057,566-3,080,132-10,100,012-15,608,831-5,493,324-9,813,666-5,562,971-7,812,409
CFO
-707k
L
-156,764-58,141-380,925-6,116-244,640-362,325-322,745-9,878,664-1,114,136-419,200850,699-706,519

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Meso Numismatics, Inc. operates with a distinctive dual focus. Primarily, it engages in the numismatic sector, serving both domestic and international markets. Its offerings include a variety of collectible items such as coins, paper currency, precious metals (bullion), and medals, which are primarily sold via live auctions. Complementing its auction activities, the company provides a specialized banknote scanner application designed to identify crucial characteristics of currency. Furthermore, it maintains an e-commerce presence through its website, mesocoins.com, for direct product sales. Beyond its numismatic operations, Meso Numismatics, Inc. has a substantial footprint in the biotechnology and regenerative medicine sector. It offers a comprehensive portfolio of advanced cellular therapies and medical solutions. This includes CELLGENIC FLOW EXOSOMES; CELLGENIC MSC, a product known for secreting growth factors, cytokines, and proteins crucial for tissue regeneration; and CELLGENIC LUMA, which is sourced from human umbilical cord mesenchymal stem cells and enriched with potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins, and UV radiation-reducing agents to promote skin revitalization. The company also provides VITANOVAS, delivering in-home treatments aimed at immune modulation to combat infections, viruses, and various diseases. Its other medical offerings encompass GCELL RESTORE, a proprietary closed-system device designed to leverage the natural restorative properties of adipose tissue; CELLGENIC SVF, an isolation kit equipped with necessary components for extracting adipose-derived stem cells; CELLGENIC BONE MARROW; and CELLGENIC Platelet Rich Plasma, utilized for its healing and anti-inflammatory benefits. Moreover, the company extends its expertise by providing training programs for medical professionals. Founded in 1999, the firm is headquartered in Boca Raton, Florida. Originally incorporated as Pure Hospitality Solutions, Inc., the organization rebranded as Meso Numismatics, Inc. in September 2018.
IPO date
Dec 28, 2001
Employees
1
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT